Racial/Ethnic Differences in Trust/Mistrust and Its Effect on Diabetes Outcomes
|ClinicalTrials.gov Identifier: NCT00383110|
Recruitment Status : Completed
First Posted : October 2, 2006
Results First Posted : September 17, 2014
Last Update Posted : April 28, 2015
- Determine racial/ethnic differences in trust in physicians and mistrust of the health care system among veterans with Type 2 Diabetes.
- Determine the predictive power of trust in physicians and mistrust of the health care system on personal health practices and health outcomes in a prospective cohort of veterans with Type 2 Diabetes
|Condition or disease|
Show Detailed Description
|Study Type :||Observational|
|Actual Enrollment :||300 participants|
|Official Title:||Racial/Ethnic Differences in Trust/Mistrust and Its Effect on Diabetes Outcomes|
|Study Start Date :||November 2004|
|Primary Completion Date :||January 2009|
|Study Completion Date :||January 2009|
Adults (age 18 or older) with type 2 diabetes.
- General Trust in Physicians Scale (GTIPS) [ Time Frame: 12 months following enrollment ]The GTIPS is a valid and reliable 11-item measure of general trust in physicians in the domains of dependability, confidence, and confidentiality of information. All items are fashioned in a 5-point Likert format with a minimum score of 11 and maximum of 55. Higher scores indicate more trust in physicians.
- Health Care System Distrust Scale [ Time Frame: 12 months after enrollment ]Health Care System Distrust Scale is a valid and reliable 10-item measure of distrust of the health care system, measuring honesty confidentiality and confidence. All questions are measured on a Likert scale, with scores ranging from a minimum of 10 to a maximum of 50. Higher scores indicate more distrust in the health care system.
- Hemoglobin A1c [ Time Frame: 12 months after enrollment ]
- Systolic Blood Pressure [ Time Frame: 12-months after enrollment ]
- Diastolic Blood Pressure [ Time Frame: 12-months after enrollment ]
- LDL-cholesterol [ Time Frame: 12-months after enrollment ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00383110
|United States, South Carolina|
|Ralph H. Johnson VA Medical Center, Charleston, SC|
|Charleston, South Carolina, United States, 29401-5799|
|Principal Investigator:||Leonard E. Egede, MD MS||Ralph H. Johnson VA Medical Center, Charleston, SC|